Consolidated Statement Of Profit Or Loss

Astellas Pharma Inc. - Filing #7595393

Concept 2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2021-04-01 to
2021-06-30
2021-04-01 to
2021-06-30
2021-04-01 to
2021-06-30
2021-04-01 to
2021-06-30
2021-04-01 to
2021-06-30
2021-04-01 to
2021-06-30
2021-04-01 to
2021-06-30
2021-04-01 to
2021-06-30
2021-04-01 to
2021-06-30
2021-04-01 to
2021-06-30
2021-04-01 to
2021-06-30
Consolidated statement of profit or loss
Statement of profit or loss
Revenue
381,791,000,000 JPY
326,143,000,000 JPY
Cost of sales
88,870,000,000 JPY
62,231,000,000 JPY
Gross profit
292,920,000,000 JPY
263,912,000,000 JPY
Selling, general and administrative expenses
153,396,000,000 JPY
137,109,000,000 JPY
Other income
16,291,000,000 JPY
403,000,000 JPY
Other expenses
38,436,000,000 JPY
27,133,000,000 JPY
Operating profit (loss)
33,147,000,000 JPY
36,090,000,000 JPY
Finance income
927,000,000 JPY
1,457,000,000 JPY
Finance costs
2,396,000,000 JPY
1,717,000,000 JPY
Share of profit (loss) of investments accounted for using equity method
350,000,000 JPY
292,000,000 JPY
Profit (loss) before tax
31,679,000,000 JPY
35,830,000,000 JPY
Income tax expense
6,867,000,000 JPY
5,144,000,000 JPY
Profit (loss)
JPY
24,812,000,000 JPY
24,812,000,000 JPY
JPY
JPY
JPY
JPY
JPY
24,812,000,000 JPY
JPY
JPY
JPY
30,687,000,000 JPY
JPY
JPY
JPY
JPY
JPY
30,687,000,000 JPY
JPY
30,687,000,000 JPY
JPY
Profit (loss) attributable to
Owners of parent
24,812,000,000 JPY
30,687,000,000 JPY
Earnings (loss) per share
Basic earnings (loss) per share
13.59
16.56
Diluted earnings (loss) per share
13.59
16.55

Talk to a Data Expert

Have a question? We'll get back to you promptly.